Vonoprazan

Overview

Vonoprazan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2079130).

API suppliers (1)

Suppliers of Vonoprazan evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• RUYUAN HEC PHARM CO LTD1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Vonoprazan expires 11 Aug 2030 and exclusivity 3 May 2032. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine

Canonical SMILES

CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3

InChIKey

BFDBKMOZYNOTPK-UHFFFAOYSA-N